
zzso zzso protein zzso in association with zzso is a significant risk factor for cardiovascular diseases and that plays a key role in the development of the zzso We evaluated serum zzso level, before and after zzso therapy in obese women with zzso zzso syndrome zzso Thirty five obese women with zzso zzso zzso aged zzso zzso were zzso Patients received zzso orally the dose of zzso zzso per zzso The patients were carefully zzso clinically zzso and laboratory tested to eliminate conditions, probable to provoke an inflammatory response which was an exclusion zzso zzso were excluded if there was clinical or zzso evidence of coronary artery disease, a family history of coronary artery disease, a history of smoking, or concurrent zzso zzso or zzso lowering zzso At all patients we determined zzso insulin, zzso zzso hormone, zzso stimulating hormone, zzso testosterone, zzso zzso zzso zzso zzso zzso and zzso profile, before and after zzso zzso Mean serum zzso levels significantly decreased after zzso treatment zzso zzso zzso zzso zzso Level of insulin reduced for 37% after zzso treatment zzso zzso zzso zzso Total cholesterol and zzso zzso cholesterol levels decreased as zzso Mean total testosterone levels decreased after zzso treatment too zzso zzso zzso zzso zzso serum zzso level significantly correlated to the zzso zzso zzso therapy in zzso women reduces zzso level, zzso and cardiovascular zzso 

